Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Vibeke Vestergaard

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Gastroenterology|May 20, 2026
Reply to "Bridging Genetics and Bedside Decisions in IBD: Utility Metrics for Susceptibility PGS"Marie Vibeke Vestergaard, Lone Larsen, Tine Jess
Nature Communications|January 21, 2026
Multimodal analysis disentangles the genetic and microbial associations between inflammatory bowel disease and other immune-mediated diseases across a harmonized population frameworkMarie Vibeke Vestergaard, Alonzo Alfaro-Núñez, Aleksejs Sazonovs, et al.
Cell Reports. Medicine|November 8, 2023
Characterizing the pre-clinical phase of inflammatory bowel diseaseMarie Vibeke Vestergaard, Kristine H Allin, Gry J Poulsen, et al.
JAMA|October 15, 2024
HLA-DRB1*01:03 and Severe Ulcerative ColitisMarie Vibeke Vestergaard, Anne Krogh Nøhr, Kristine Højgaard Allin, et al.
Plos One|October 6, 2021
Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synucleinSara Elfarrash, Nanna Møller Jensen, Nelson Ferreira, et al.
United European Gastroenterology Journal|December 2, 2023
Gut microbiota signatures in inflammatory bowel diseaseMarie Vibeke Vestergaard, Kristine H Allin, Carsten Eriksen, et al.
Journal of Gastroenterology|July 4, 2025
New potential biomarkers of ulcerative colitis and disease course - integrated metagenomic and metabolomic analysis among Polish patientsOliwia Zakerska-Banaszak, Karolina Ladziak, Dariusz Kruszka, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 31, 2025
Large-scale clustering of longitudinal fecal calprotectin and C-reactive protein profiles in inflammatory bowel diseaseNathan Constantine-Cooke, Marie Vibeke Vestergaard, Nikolas Plevris, et al.
Gastroenterology|February 10, 2026
Genetic Risk of Inflammatory Bowel Disease Is Associated With Disease Course SeverityMarie Vibeke Vestergaard, Kristine Højgaard Allin, Anne Krogh Nøhr, et al.
The New England Journal of Medicine|June 10, 2026
Interleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel DiseaseNima Gharahdaghi, Pai-Jui Yeh, Lourdes Ceron-Gutierrez, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Gastroenterology|May 20, 2026
Reply to "Bridging Genetics and Bedside Decisions in IBD: Utility Metrics for Susceptibility PGS"Marie Vibeke Vestergaard, Lone Larsen, Tine Jess
Nature Communications|January 21, 2026
Multimodal analysis disentangles the genetic and microbial associations between inflammatory bowel disease and other immune-mediated diseases across a harmonized population frameworkMarie Vibeke Vestergaard, Alonzo Alfaro-Núñez, Aleksejs Sazonovs, et al.
Cell Reports. Medicine|November 8, 2023
Characterizing the pre-clinical phase of inflammatory bowel diseaseMarie Vibeke Vestergaard, Kristine H Allin, Gry J Poulsen, et al.
JAMA|October 15, 2024
HLA-DRB1*01:03 and Severe Ulcerative ColitisMarie Vibeke Vestergaard, Anne Krogh Nøhr, Kristine Højgaard Allin, et al.
Plos One|October 6, 2021
Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synucleinSara Elfarrash, Nanna Møller Jensen, Nelson Ferreira, et al.
United European Gastroenterology Journal|December 2, 2023
Gut microbiota signatures in inflammatory bowel diseaseMarie Vibeke Vestergaard, Kristine H Allin, Carsten Eriksen, et al.
Journal of Gastroenterology|July 4, 2025
New potential biomarkers of ulcerative colitis and disease course - integrated metagenomic and metabolomic analysis among Polish patientsOliwia Zakerska-Banaszak, Karolina Ladziak, Dariusz Kruszka, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 31, 2025
Large-scale clustering of longitudinal fecal calprotectin and C-reactive protein profiles in inflammatory bowel diseaseNathan Constantine-Cooke, Marie Vibeke Vestergaard, Nikolas Plevris, et al.
Gastroenterology|February 10, 2026
Genetic Risk of Inflammatory Bowel Disease Is Associated With Disease Course SeverityMarie Vibeke Vestergaard, Kristine Højgaard Allin, Anne Krogh Nøhr, et al.
The New England Journal of Medicine|June 10, 2026
Interleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel DiseaseNima Gharahdaghi, Pai-Jui Yeh, Lourdes Ceron-Gutierrez, et al.
Pageof 1